Bristol-Myers Squibb (BMY)
59.50
-1.49 (-2.44%)
At close: Apr 01, 2025, 3:59 PM
59.59
0.14%
Pre-market: Apr 02, 2025, 04:35 AM EDT
Opdivo Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Jun 30, 2023 | 2.15B | -57M | -2.59% |
| Mar 31, 2023 | 2.2B | -14M | -0.63% |
| Dec 31, 2022 | 2.22B | 169M | +8.26% |
| Sep 30, 2022 | 2.05B | -16M | -0.78% |
| Jun 30, 2022 | 2.06B | 2.06B | +34283.33% |
| Mar 31, 2022 | 6M | -858M | -99.31% |
| Dec 31, 2021 | 864M | -6M | -0.69% |
| Sep 30, 2021 | 870M | 56M | +6.88% |
| Jun 30, 2021 | 814M | 702M | +626.79% |
| Mar 31, 2021 | 112M | -3M | -2.61% |
| Dec 31, 2020 | 115M | 19M | +19.79% |
| Sep 30, 2020 | 96M | -2.79B | -96.67% |
| Jun 30, 2020 | 2.88B | -31M | -1.06% |
| Mar 31, 2020 | 2.92B | n/a | n/a |
| Dec 31, 2019 | n/a | n/a | n/a |
| Sep 30, 2019 | n/a | n/a | n/a |
| Jun 30, 2019 | n/a | n/a | n/a |
| Mar 31, 2019 | n/a | n/a | n/a |
| Dec 31, 2018 | n/a | n/a | n/a |
| Sep 30, 2018 | n/a | n/a | n/a |
| Jun 30, 2018 | n/a | n/a | n/a |
| Mar 31, 2018 | n/a | n/a | n/a |
| Dec 31, 2017 | n/a | n/a | n/a |
| Sep 30, 2017 | n/a | n/a | n/a |
| Jun 30, 2017 | n/a | n/a | n/a |
| Mar 31, 2017 | n/a | n/a | n/a |
| Dec 31, 2016 | n/a | n/a | n/a |
| Sep 30, 2016 | n/a | n/a | n/a |
| Jun 30, 2016 | n/a | n/a | n/a |
| Mar 31, 2016 | n/a | n/a | n/a |
| Dec 31, 2015 | n/a | n/a | n/a |
| Sep 30, 2015 | n/a | n/a | n/a |
| Jun 30, 2015 | n/a | n/a | n/a |
| Mar 31, 2015 | n/a | n/a | n/a |
| Dec 31, 2014 | n/a | n/a | n/a |
| Sep 30, 2014 | n/a | n/a | n/a |
| Jun 30, 2014 | n/a | n/a | n/a |
| Mar 31, 2014 | n/a | n/a | n/a |
| Dec 31, 2013 | n/a | n/a | n/a |
| Sep 30, 2013 | n/a | n/a | n/a |
| Jun 30, 2013 | n/a | n/a | n/a |